West Pharmaceutical Services Inc
NYSE:WST
EV/OCF
Enterprise Value to OCF
Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.
Market Cap | EV/OCF | ||||
---|---|---|---|---|---|
US |
West Pharmaceutical Services Inc
NYSE:WST
|
24.2B USD | 31.3 | ||
US |
Thermo Fisher Scientific Inc
NYSE:TMO
|
222.9B USD | 27.6 | ||
US |
Danaher Corp
NYSE:DHR
|
194.6B USD | 29.3 | ||
US |
Agilent Technologies Inc
NYSE:A
|
44.1B USD | 22.9 | ||
US |
IQVIA Holdings Inc
NYSE:IQV
|
41.8B USD | 23.5 | ||
CH |
Lonza Group AG
SIX:LONN
|
37B CHF | 27.3 | ||
KR |
Samsung Biologics Co Ltd
KRX:207940
|
53.4T KRW | 31.8 | ||
US |
Mettler-Toledo International Inc
NYSE:MTD
|
31.6B USD | 33.3 | ||
IE |
ICON PLC
NASDAQ:ICLR
|
26.5B USD | 22.5 | ||
US |
Waters Corp
NYSE:WAT
|
20B USD | 32.3 | ||
FR |
Sartorius Stedim Biotech SA
PAR:DIM
|
17.3B EUR | 30.9 |
EV/OCF Forward Multiples
Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.